Literatur
Brown PD, Gondi V, Pugh S et al (2020) Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol. https://doi.org/10.1200/JCO.19.02767
Gondi V, Hermann BP, Mehta MP, Tomé WA (2012) Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys 83:e487–e493
Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8:955–962
Brown PD, Pugh S, Laack NN et al (2013) Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 15:1429–1437
Gondi V, Pugh SL, Tome WA et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32:3810–3816
Connor M, Karunamuni R, McDonald C et al (2017) Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol 123:209–217
Krayenbuehl J, Di Martino M, Guckenberger M, Andratschke N (2017) Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial. Radiat Oncol 12:161
Mayinger M, Kraft J, Lohaus N et al (2020) Leukoencephalopathy after prophylactic whole-brain irradiation with or without hippocampal sparing: a longitudinal magnetic resonance imaging analysis. Eur J Cancer 124:194–203
De Ruysscher D, Dingemans AMC, Praag J et al (2018) Prophylactic cranial irradiation versus observation in radically treated stage III non--small-cell lung cancer: a randomized phase III NVALT-11/DLCRG-02 study. J Clin Oncol 36:2366–2377
Belderbos J, De Ruysscher D et al (2019) OC-0503 phase III trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC. Radiother Oncol 133:S259
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Mayinger und N. Andratschke geben an, dass kein Interessenkonflikt besteht.
Additional information
Originalpublikation
Brown PD, Gondi V, Pugh S et al. (2020) Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG Oncology CC001. J Clin Oncol 1;38(10):1019–1029. https://doi.org/10.1200/JCO.19.02767
Rights and permissions
About this article
Cite this article
Mayinger, M., Andratschke, N. Stellenwert der Hippocampusschonung bei therapeutischer Ganzhirnbestrahlung. Strahlenther Onkol 196, 844–846 (2020). https://doi.org/10.1007/s00066-020-01642-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-020-01642-8